Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

Delayed Quote. Delayed  - 07/22 10:02:01 pm
57.58 USD   -2.16%
07/18 CAMBREX : Charles City expansion project is complete
07/14 CAMBREX : Completes $50 Million Investment in Large Scale API Manufa..
07/13 CAMBREX : Completes $50 million Investment in Large Scale API Manufa..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
58.06(c) 57.88(c) 58.85(c) 58.85(c) 57.58(c) Last
316 404 210 274 294 902 217 890 381 397 Volume
+0.55% -0.31% +1.68% 0.00% -2.16% Change
More quotes
Financials ($)
Sales 2016 475 M
EBIT 2016 119 M
Net income 2016 80,0 M
Debt 2016 -
Yield 2016 -
Sales 2017 526 M
EBIT 2017 136 M
Net income 2017 90,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 23,63
P/E ratio 2017 20,94
Capi. / Sales2016 3,87x
Capi. / Sales2017 3,50x
Capitalization 1 841 M
More Financials
Company
Cambrex Corp. engages in the provisio ofproducts, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services to innovator and generic pharmaceutical companies.Its products include generic and... 
Sector
Pharmaceuticals
Calendar
11/01Earnings Release
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
07/18 CAMBREX : Charles City expansion project is complete
07/14 CAMBREX : Completes $50 Million Investment in Large Scale API Manufacturing and ..
07/13 CAMBREX : Completes $50 million Investment in Large Scale API Manufacturing and ..
07/12 Cambrex Completes $50 Million Investment in Large Scale API Manufacturing and..
07/05 Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
06/06 CAMBREX : to Present at the Jefferies 2016 Global Healthcare Conference
06/03 Cambrex to Present at the Jefferies 2016 Global Healthcare Conference
05/23 Cambrex Announces Closing of New $500 Million Senior Credit Facility
05/16 Cambrex to Present at UBS Global Healthcare Conference
05/03 CAMBREX : Reports First Quarter 2016 Financial Results; Sales increased 20% and ..
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/13 Caterpillar Is A Buy - Cramer's Lightning Round (7/12/16)
05/28 LANNETT : Structural Benefits Of The Kremers Acquisition: 100+% Upside
04/30 Cambrex's (CBM) CEO Steven Klosk on Q1 2016 Results - Earnings Call Transcrip..
04/29 Cambrex revenues up 20%; earnings up 76%; Non-GAAP EPS up 72% in Q1, updates ..
04/29 Cambrex beats by $0.16, beats on revenue
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 54,8 $
Spread / Average Target -4,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Gregory P. Sargen Chief Financial Officer & Executive Vice President
Peter G. Tombros Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION22.28%1 841
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results